LeMaitre Vascular Inc.
LMAT | NASDAQ
$79.20
+$0.33 (+0.42%)
At close: Sep 21, 2026, 4:00 PM ET
$79.20
$0 (0.00%)
Pre-market:
Sep 22, 2026, 5:55 AM ET
Company Profile
Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi. The company also furnishes carotid shunts, designed to temporarily redirect blood flow to the brain during carotid endarterectomy surgery to clear arterial plaque. Another offering is radiopaque tape, a medical-grade adhesive applied externally to help interventionists precisely cross-reference skin locations with underlying anatomical features like vessels or lesions. Further products include valvulotomes, instruments used to cut or disrupt valves within the saphenous vein, enabling it to function as an arterial bypass to carry blood past diseased arteries to the lower leg or foot. Additionally, LeMaitre supplies vascular grafts for bypassing or replacing compromised arteries. Moreover, the company provides vascular and cardiac patches for post-surgical vessel closure. Its closure systems employ titanium clips for connecting vessels, offering an alternative to traditional sutures. Products are distributed via both its direct sales force and a network of distributors. Founded in 1983 as Vascutech, Inc., the company rebranded as LeMaitre Vascular, Inc. in April 2001. It is headquartered in Burlington, Massachusetts.
Key Executives
| Name | Position |
|---|---|
| George W. LeMaitre | Chairman & Chief Executive Officer |
| Dorian LeBlanc | Chief Financial Officer |
| Laurie A. Churchill | Chief Legal Officer |
| Daniel J. Mumford | Senior Director of Human Resources |
| David Roberts | President & Director |
| George D. LeMaitre FACS | Founder and Chairman of Scientific Advisory Board |
| Jonathan W. Ngau | Senior Vice President of Information Technology |
| Kimberly L. Cieslak | Vice President of Marketing |
| Maik D. Helmers | Senior Vice President of Sales Central Europe |
| Trent G. Kamke | Senior Vice President of Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 03, 2026 | 4 | Filing |
| Aug 05, 2026 | 10-Q | Quarterly Report |
| Aug 04, 2026 | 8-K | Current Report |
| Jul 27, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Jun 05, 2026 | 4 | Filing |
| Jun 05, 2026 | 4 | Filing |
| Jun 05, 2026 | 4 | Filing |
| Jun 05, 2026 | 4 | Filing |
| Jun 05, 2026 | 4 | Filing |
| Jun 05, 2026 | 4 | Filing |
LeMaitre Vascular Inc.
| Country | United States |
| IPO Date | Oct 18, 2006 |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Employees | 651 |
| CEO | George W. LeMaitre |
Contact Details
63 Second Avenue Burlington,
Massachusetts 01803 United States
Stock Details
| Ticker Symbol | LMAT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001158895 |
| CUSIP Number | 525558201 |
| ISIN Number | US5255582018 |
| SIC Code | 3841 |
Recent News
- 26 days ago / globenewswire.comLeMaitre to Participate at Upcoming Investor Conferences in September
- 1 month ago / seekingalpha.comLeMaitre Vascular: 31% Drawdown On $0.02 Guidance Cut
- 2 months ago / globenewswire.comLeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
- 2 months ago / seekingalpha.comLeMaitre Vascular, Inc. (LMAT) Q2 2026 Earnings Call Transcript
- 2 months ago / marketbeat.comLeMaitre Vascular Q2 Earnings Call Highlights
- 2 months ago / zacks.comLeMaitre Vascular (LMAT) Q2 Earnings and Revenues Lag Estimates
- 2 months ago / globenewswire.comLeMaitre Q2 2026 Financial Results
- 2 months ago / globenewswire.comLeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026
- 4 months ago / zacks.comLeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why
- 4 months ago / globenewswire.comLeMaitre to Participate at Upcoming Investor Conferences in June
Add to Watchlist
Select watchlists to add or remove LMAT